Skin in the game: Existing and upcoming physician payment models in dermatology

Ogbechie-Godec, Oluwatobi A; Mostaghimi, Arash; Nambudiri, Vinod E.

doi:10.1016/j.jaad.2018.01.032

Cited by 3 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the findings of this study underscore the importance of adopting value-based payment models that link reimbursement to patient outcomes, rather than the volume of procedures. 13 In order to build value-based payment models, dermatologists must first define the optimal treatment modalities for different subsets of skin cancer patients. 14 To date, only one randomized controlled clinical trials has been performed comparing MMS to wide local excision for basal cell carcinoma.…”

Section: Resultsmentioning

confidence: 99%

Use of Skin Cancer Procedures, Medicare Reimbursement, and Overall Expenditures, 2012-2017

Puri

Baliga

Pittelkow

et al. 2020

Preprint

View full text Add to dashboard Cite

The treatment of skin cancers represents a growing share of healthcare expenditures. At the same time, Medicare reimbursement rates for physician services have declined with respect to inflation. The objective of this study was to describe the economic effects of declining Medicare reimbursement for skin cancer procedures. In this ecological study, we used the Medicare Physician Supplier and Other Provider Public Use File (POSPUF) to analyze trends in Medicare reimbursement rates, use rates, and overall Medicare expenditures for skin cancer procedures from 2012 to 2017. We adjusted reimbursement rates for inflation by converting payment amounts into units of 2017 dollars. From 2012 to 2017, overall inflation-adjusted Medicare expenditure on skin cancer procedures increased 9%. Over this time period, inflation-adjusted Medicare reimbursement rates declined for each procedure class, with the exception of shave excision. Concurrently, the use rate of Mohs micrographic surgery increased 23%, while the use rate for all other skin cancer procedure classes declined. In summary, this study describes trends suggesting declining Medicare reimbursement rates have been associated with increasing use rates for higher cost skin cancer procedures. Clinicians and policy makers should collaborate to develop value-based payment models that incentivize patient outcomes rather than procedural volumes.

show abstract

Section: Resultsmentioning

confidence: 99%

Use of Skin Cancer Procedures, Medicare Reimbursement, and Overall Expenditures, 2012-2017

Puri

Baliga

Pittelkow

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Studies have shown a lack of familiarity with principles in health policy and practice management among residents and recent graduates across a number of medical specialties [1][2][3][4][5], prompting numerous proposals and calls to action to improve health policy education within graduate medical education [6][7][8][9][10][11]. Although studies have characterized business preparedness among dermatology trainees [12,13], efforts to understand and educate dermatology trainees about health policy reforms pertaining to dermatology practice have not been required or standardized across dermatology residency programs [14][15][16]. Thus, the goal of this study was to characterize the extent of prior health policy education and experiences among current U.S. dermatology residents, to assess their level of health systems knowledge and health policy literacy, and to characterize desire for further education and future involvement in health policy activities.…”

Section: Introductionmentioning

confidence: 99%